Fiscal First Half 2024 Highlighted by Ongoing Cost Reduction Initiatives Resulting in $3.6 Million Year-Over-Year Decrease in Operating Expenses Partnerships […]
MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade […]
Balance sheet restructuring designed to strengthen View’s financial position Approvals received from key stakeholders across capital structure MILPITAS, Calif., April […]
SAN CARLOS, Calif., April 02, 2024 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity […]
Clinical results demonstrate long-term efficacy of the OMNI® Surgical System for primary open-angle glaucoma and support use of TearCare® technology […]